ModiQuest (CRO) focus is on generation of recombinant monoclonal antibodies (animal, human). The company use antigen specific B-cell selection combined with efficient hybridoma generation or direct antibody cDNA cloning from selected B-cells. MQR off...Show all
Phone:
Schoutstraat 58
6525 XV
Netherlands
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-07-02 | Citryll | Series B | $20.8M | BioGeneration Ventures, BOM Brabant Ventures, BrightGene Bio-Medical Technology, and Seventure Partners |
2019-07-03 | Citryll | Series A | $16.94M | BOM Brabant Ventures, BrightGene Bio-Medical Technology, and Curie Capital |